
|Articles|April 1, 2002
- Volume 0 0
Early and Aggressive Intervention in RA Crucial
Advertisement
A recent study conducted at Turku University in Finland highlights the urgency of early and aggressive treatment of rheumatoid arthritis (RA). The study examined the impact of delaying treatment for symptoms on whether disease remission is achieved; it also assessed the efficacy of single-drug therapy vs combination therapy. Researchers found that those in the group whose treatment was delayed fared worst, whereas those who received an aggressive combination-therapy regimen fared best.
Articles in this issue
about 24 years ago
Blood Pressure Drugs May Improve Fitness in the Elderlyabout 24 years ago
Fast Facts on Osteoporosisabout 24 years ago
Take Tea and See?Higher Bone Densityabout 24 years ago
New Fish Advisory Coming for Pregnant Womenabout 24 years ago
Fitness Mattersabout 24 years ago
Systolic Measurement Better Indicator of Mortality Riskabout 24 years ago
Higher Activity = Lower Blood Pressureabout 24 years ago
Juan Valdez and Starbucks Would Smileabout 24 years ago
ASTHMA Underdiagnosed and Undertreatedabout 24 years ago
Pharmacists Important Asthma CounselorsAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
3
ADA 2026: Optimized Inhaled Insulin Dosing Outperforms Subcutaneous Analogs for Postprandial Glucose in T1D
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5






































































































































